These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30845110)
1. Managing oncology drug costs in a constrained environment. Clark P Clin Adv Hematol Oncol; 2019 Feb; 17(2):90-93. PubMed ID: 30845110 [No Abstract] [Full Text] [Related]
2. ASCO Rx for high drug costs: doctors and patients need to talk. Nicholas J J Natl Cancer Inst; 2009 Nov; 101(21):1441-4. PubMed ID: 19828870 [No Abstract] [Full Text] [Related]
3. Value in Oncology: It Is in the Eyes of the Beholder. Nabhan C; Phillips EG; Feinberg BA J Natl Compr Canc Netw; 2019 Jan; 17(1):2-5. PubMed ID: 30659123 [No Abstract] [Full Text] [Related]
4. Seeking value as cancer drug costs soar. Bender E Cancer Discov; 2013 Aug; 3(8):833-4. PubMed ID: 23928760 [TBL] [Abstract][Full Text] [Related]
5. Managed care & medical oncology: the focus is on value. Danielson E; Demartino J; Mullen JA J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721 [TBL] [Abstract][Full Text] [Related]
6. [The costs of oncology. Results of an innovative research]. Piccinini M; Nicolis F; Venturini M Tumori; 2008; 94(3):1-4. PubMed ID: 18705421 [No Abstract] [Full Text] [Related]
7. Many new cancer drugs in the United Kingdom are facing negative NICE rulings. Low E; J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049 [No Abstract] [Full Text] [Related]
8. Keynote comment: Cancer drug pricing in the USA. Johnson DH Lancet Oncol; 2006 Jun; 7(6):444-5. PubMed ID: 16750490 [No Abstract] [Full Text] [Related]
9. Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology. American Society of Clinical Oncology J Oncol Pract; 2014 Jul; 10(4):259-63. PubMed ID: 24737877 [No Abstract] [Full Text] [Related]
10. Reforming the payment system for medical oncology. Bach PB JAMA; 2013 Jul; 310(3):261-2. PubMed ID: 23817729 [No Abstract] [Full Text] [Related]
11. Cancer care value-learning from others. Gamble RB Am J Manag Care; 2012 May; 18(3 Spec No.):SP139. PubMed ID: 22642284 [No Abstract] [Full Text] [Related]
12. United healthcare, five oncology practices try bundled payments. Goozner M J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535 [No Abstract] [Full Text] [Related]
13. Novel approaches to delivering value in oncology drugs. Miller S Clin Adv Hematol Oncol; 2016 Apr; 14(4):244-6. PubMed ID: 27166606 [No Abstract] [Full Text] [Related]
14. Biosimilars in Oncology: Reality Could Bite the Copycats, Dog Potential Major Savings. Kelley T Manag Care; 2017 Mar; 26(3):28-30. PubMed ID: 28510517 [TBL] [Abstract][Full Text] [Related]
15. The shortage of essential chemotherapy drugs in the United States. Gatesman ML; Smith TJ N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130 [No Abstract] [Full Text] [Related]
16. Tackling Cost: A Prescription for Spending Wisely. Tempero M J Natl Compr Canc Netw; 2019 Jun; 17(6):633. PubMed ID: 31200360 [No Abstract] [Full Text] [Related]
17. Key factors impacting the delivery and financing of oncology care in the United States. Goldsmith PJ; Paivanas T J Natl Compr Canc Netw; 2006 May; 4(5):434-7. PubMed ID: 16715607 [No Abstract] [Full Text] [Related]
18. Managing oncology products. Penna P Manag Care Interface; 2005 Jun; 18(6):41-2. PubMed ID: 16018298 [No Abstract] [Full Text] [Related]
19. Recent legislation changes the economics of cancer care. Silberman G; Downs CG ONS News; 2005 Jul; 20(7):9. PubMed ID: 16045235 [No Abstract] [Full Text] [Related]
20. Can cancer care lead the way toward a value-based future? Macmillan K Am J Manag Care; 2019 Dec; 25(12 Spec No.):SP377-SP378. PubMed ID: 31860249 [No Abstract] [Full Text] [Related] [Next] [New Search]